Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
Pharmaceutical firms are developing and reshaping their Rx-to-OTC switch strategies to remain competitive in an evolving industry where recent mergers and acquisitions underscore the importance of an OTC presence and switch platform
More from Archive
More from Pink Sheet
After an Aug. 6 safety labeling change, the FDA became aware of “more compelling evidence” that the risk for serious chikungunya-like illness is not limited to older adults, CBER Director Prasad said.
Generic drug industry representatives applauded the FDA decision to bring back key staff in the Office of Generic Drugs that were laid off earlier this year.
The White House is directing the Health and Human Services Department to replenish stockpiles of active pharmaceutical ingredients for “especially critical” medicines.